September 12, 2014
A New Jersey federal judge on Friday dismissed an antitrust suit in multidistrict litigation challenging a purportedly anti-competitive patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Ltd. over Lipitor, ruling a proposed class of pharmaceutical wholesalers and retailers failed to state a claim.
November 19, 2013
A New Jersey federal judge on Monday released Daiichi Sankyo Inc. from multidistrict antitrust litigation challenging a patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Inc. over Pfizer's cholesterol drug Lipitor, in which Daiichi Sankyo claimed it had no involvement.
January 17, 2013
Cohen Milstein Sellers & Toll PLLC will remain in multidistrict litigation over Pfizer Inc.'s alleged efforts to keep a generic form of Lipitor off the market after a New Jersey federal judge on Thursday rebuffed Blue Cross Blue Shield of Louisiana's bid to oust the firm.
November 19, 2012
Pfizer Inc. sought Friday to end a class action concerning its purportedly anti-competitive settlement resolving patent litigation over Ranbaxy Inc.'s generic challenge to Pfizer's cholesterol drug Lipitor, telling a New Jersey federal court that the drug retailer plaintiffs lack standing to pursue the case.
October 25, 2012
A New Jersey judge has refused to halt multidistrict antitrust litigation challenging patent infringement settlements Pfizer Inc. reached over its cholesterol treatment Lipitor, ruling that waiting for the U.S. Supreme Court to take and decide similar suits over pay-for-delay deals would stall the case too long.